The 2020 Event Has Run: Thank You to Our Speakers, Sponsors and Delegates for Joining Us at the Digital Meeting! Get updates on our next meeting here.
The Digital Mitochondria-Targeted Drug Development Summit is the only industry-led meeting focused on end-to-end mitochondria-targeting. Explore success stories from leading experts overcoming common challenges whilst exploring what’s next to help you accelerate your pipeline into the clinic.
With 20+ hours of content, 2 interactive workshops and over 5 hours of networking with key industry leaders from Larimar Therapeutics, Minovia Therapeutics, Mitokinin and many more, this comprehensive forum will completely focus on mitochondria-targeting drug development and the current challenges and opportunities in the field.
Make this your 2021 must-attend meeting and network with 80+ senior CSOs, CEOs, research scientists, academics and investors committed to targeting mitochondria to tackle challenges with Mitochondrial & Age-related Diseases.
In this focused summit, you’ll learn from the field's pioneers who’ll be sharing their experience in:
Exploring the role of mitochondrial dysfunction in age-related diseases & rare genetic mitochondrial diseases
Examining early discovery and research findings
Evaluating preclinical drug development and studies
Discovering the patient perspective to aid mitochondria-targeted drug development
Assessing clinical development and showcasing current trials
Lessons learned from clinical trial design and how design can be improved to mitigate common challenges
Realizing the use of gene therapy, editing technology and innovation